— Those with presumed exposure now eligible
by Kristina Fiore | June 29, 2022
The U.S. is expanding its monkeypox vaccination strategy to include those with a presumed exposure to monkeypox, not just a confirmed exposure, federal officials announced Tuesday evening.
The new strategy takes into account the limited doses of the preferred vaccine, Jynneos, according to CDC Director Rochelle Walensky, MD.… Read the rest
Tag: Jynneos
Pro-Vaccine Masses Who Survived COVID Injections Targeted for Monkeypox Vaccines as Depopulation Plans Advance
by Brian Shilhavy | June 29, 2022
It was announced this week that the CDC has ordered 1.6 million doses of Bavarian Nordic’s smallpox and monkeypox vaccines to be injected into people during the second half of 2022, starting with 56,000 doses immediately, another 240,000 doses in the coming weeks, then another 750,000 doses over the rest of the summer with another 500,000 doses in the fall.… Read the rest
The Five Phases to Get You a Monkeypox Vaccine
It’s the best case scenario for the worst case scenario.
By Tony Ho Tran
When it comes to monkeypox, there’s good news and bad news.
The bad news: Monkeypox doesn’t look like it’s going away anytime soon. In fact, a rise in cases throughout the United States in recent weeks has stirred concerns (and confusion) from officials at the Centers for Disease Control and Prevention (CDC).… Read the rest
CDC: No Evidence Monkeypox Is Airborne
— 45 cases in the U.S. so far, and not all from international travel
by Molly Walker | June 10, 2022
There is currently no evidence that monkeypox is airborne, CDC officials said on Friday.
To date, 45 cases across 15 states and Washington, D.C. have been reported — and not all are linked to international travel — but no deaths have been associated with the outbreak, CDC Director Rochelle Walensky, MD, said on a conference call with reporters.… Read the rest